Problems with the tobacco products scientific advisory committee (TPSAC) list of harmful or potentially harmful tobacco and/or tobacco smoke components

Beitrage zur Tabakforschung International/ Contributions to Tobacco Research

Volumn 24, Issue 6, 2011, Pages 258-276

  Rodgman, Alan ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTIANA TABACUM;

EID: 84856154198     PISSN: 0173783X     EISSN: 16129237     Source Type: Journal    
DOI: 10.2478/cttr-2013-0907     Document Type: Article

References (112)

1. International Agency for Research on Cancer (IARC): Evaluation of the carcinogenic risk of chemicals to humans: Tobacco smoking; IARC, Lyon, France, IARC Monograph 38 (1986).
2. Hoffmann, D. and E.L. Wynder: Chemical constituents and bioactivity of tobacco smoke; in: Tobacco: A major health hazard, edited by D.G. Zardidze and R. Peto, IARC, Lyon, France, IARC Sci. Publ. No. 74 (1986) 145-165.
3. Hoffmann, D. and S.S. Hecht: Advances in tobacco carcinogenesis; in: Chemical carcinogenesis and mutagenesis, edited by C.S. Cooper and P. Grover, Springer Verlag, London, UK (1990) 64-102.
4. Hoffmann, D., A. Rivenson, F.L. Chung, and E.L. Wynder: Potential inhibitors of tobacco carcinogenesis; in: Tobacco smoking and nutrition: Influence of nutrition on tobacco-associated health risks, edited by J.N. Diana and W.A. Pryor, Ann. N.Y. Acad. Sci. 686 (1993) 140-160.
5. Hoffmann, D. and I. Hoffmann: [Chemical studies on tobacco smoke. C.] The changing cigarette: 1950-1995; J. Toxicol. Environ. Hlth. 50 (1997) 307-364.
6. Hoffmann, D. and I. Hoffmann: Tobacco smoke components. Letter to the Editor; Beitr. Tabakforsch. Int. 18 (1998) 49-52.
7. Hoffmann, D. and I. Hoffmann: The changing cigarette: Chemical studies and bioassays; Chapter 5 in: Risks associated with smoking cigarettes with low machinemeasured yields of tar and nicotine, NCI Smoking and Tobacco Control, Monograph 13, edited by D.M. Burns and N.L. Benowitz, Bethesda, MD, (2001) 159-191.
8. Hoffmann, D., I. Hoffmann, and K. El-Bayoumy: The less harmful cigarette: A controversial issue. A tribute to Ernst L. Wynder; Chem. Res. Toxicol. 14 (2001) 767-790.
9. Fowles, J. and M. Bates: The chemical constituents in cigarettes and cigarette smoke: Priorities for harm reduction; A Report to the New Zealand Ministry of Health, March 2000, pp. 1-65, see www.ndp.govt.nz/tobacco/documents/tobaccochem.pdf.
10. Occupational Safety and Health Administration (OSHA): Indoor air quality; Fed. Reg. 59 (No. 65) (1994) 15968-16039.
11. Closing Quotes Department: Dietrich Hoffmann: Author of the list; Tobacco Reporter (July 2002) 70-72.
12. Rodgman, A.: The composition of cigarette smoke: Problems with lists of tumorigens; Beitr. Tabakforsch. Int. 20 (2003) 402-437.
13. Rodgman, A. and C.R. Green: Toxic chemicals in cigarette mainstream smoke-hazard and hoopla; in: Cigarette risk and the potential for risk reduction; Proc. of the 2002 CORESTA Congress, New Orleans, LA, pp. 2-52, see www.rjrtdocs.com 526909637-9687; Beitr. Tabakforsch. Int. 20 (2003) 481-545.
14. Tobacco Products Scientific Advisory Committee (TPSAC): Draft initial list of harmful/potentially harmful constituents in tobacco smoke or smokeless tobacco products; August 2010.
15. Shear, M.J. and J. Leiter: Studies in carcinogenesis. XVI. Production of subcutaneous tumors in mice by miscellaneous polycyclic compounds; J. Natl. Cancer Inst. 2 (1941) 241-258.
16. Fay, J.R., L.R. Perry, L.A. Kanerva, C.C. Sigman, and C.T. Helmes: Inhibitors of chemical carcinogenesis; Document prepared in 1984, revised in 1985 for the Office of the Scientific Coordinator for Environmental Cancer, NCI, Bethesda, MD (1985) 1-96.
17. Kennaway, E.L. and I. Hieger: Carcinogenic substances and their fluorescent spectra; Brit. Med. J. 1 (1930) 1044-1046.
18. Cook, J.W., C.L. Hewitt, and I. Hieger: Isolation of a cancer-producing hydrocarbon from coal tar. II. Isolation of 1,2- and 4,5-benzpyrenes, perylene, and 1,2- benzanthracene; J. Chem. Soc. (1933) 395-398; Barry, G., J.W. Cook, G.A.D. Haslewood, C.L. Hewett, I. Hieger, and E.L. Kennaway: The production of cancer by pure hydrocarbons. Part III; Proc. Royal Soc. (Biol.) 117 (1935) 318-351.
19. Hartwell, J.L.: Survey of compounds which have been tested for carcinogenic activity; USPHS Publ. No. 149, 2nd Edition, Washington, DC (1951).
20. Shubik, P. and J.L. Hartwell: Survey of compounds which have been tested for carcinogenic activity, Suppl. 1; USPHS Publ. No. 149, Washington, DC (1957).
21. Dipple, A.: Polynuclear aromatic hydrocarbons; in: Chemical carcinogens, 1st edition, edited by C.E. Searle, American Chemical Society Monograph 173 (1976) 245-314.
22. Steiner, P.E. and H.L. Falk: Summation and inhibition effects of weak and strong carcinogenic hydrocarbons, 1:2-benzanthracene, chrysene, 1:2:5:6-dibenzanthracene, and 20-methylcholanthrene; Cancer Res. 11 (1951) 56-63.
23. Hill, W.T., D.W. Stanger, A. Pizzo, B. Riegel, P. Shubik, and W.B. Wartman: Inhibition of 9,10-dimethyl-1,2- benzanthracene skin carcinogenesis in mice by polycyclic hydrocarbons; Cancer Res. 11 (1951) 892-897.
24. Wynder, E.L. and D. Hoffmann: Tobacco and tobacco smoke: Studies in experimental carcinogenesis; Academic Press, New York, NY (1967).
25. Crabtree, H.G.: Some effects of aromatic hydrocarbons on sulfur metabolism and tumor induction in mice; Cancer Res. 6 (1946) 553-559; Anticarcinogenesis; Brit. Med. Bull. 4 (1947) 345; Influence of bromobenzene on the induction of skin tumors by 3,4-benzopyrene; Cancer Res. 4 (1944) 688-693; Influence of unsaturated dibasic acids on the induction of skin tumors by chemical carcinogens; Cancer Res. 5 (1945) 346-351.
26. Wynder, E.L. and D. Hoffmann: Studies with the gaseous and particulate phase of tobacco smoke; Proc. Am. Assoc. Cancer Res. 3(4) (1962) 373.
27. Kallistratos, G.: Verhinderung der 3,4-Benzopyrenkanzerogenese durch natürliche und synthetische Verbindungen [Inhibition of 3,4-benzopyrene carcinogenesis by natural and synthetic compounds]; Münch. Med. Wochenschr. 117 (1975) 391-394.
28. Kallistratos, G. and E. Fasske: Biologische inactivierung kanzerogener Stoffe [Biological inactivation of carcinogenic substances]; Folia Biochem. Biol. Graeca 13 (1976) 94-107.
29. Wattenberg, L.W., J.B. Coccia, and K.T. Lam: Inhibitory effects of phenolic compounds on benzo[a]pyreneinduced neoplasia; Cancer Res. 40 (1980) 2820-2823.
30. Wattenberg, L.W.: Inhibitors of chemical carcinogens; in: Cancer: Achievements, challenges and prospects for the 1980's, edited by J.H. Burchenal, Grune and Stratton, New York, NY (1981) 517-539.
31. Wattenberg, L.W., L.K.T. Lam, and A.V. Fladmoe: Inhibition of chemical carcinogen-induced neoplasia by coumarins and α-angelica lactone; Cancer Res. 39 (1979) 1651-1654.
32. Berry, D.L., T.J. Slaga, J. DiGiovanni, and M.R. Juchau: Chlorinated dibenzo-p-dioxins, polybrominated biphenyls, and polychlorinated biphenyls in a two-stage system of mouse skin tumorigenesis: Potent anticarcinogenic effects; Ann. NY Acad. Sci. 320 (1979) 405-414.
33. Cohen, G.M., W.P. Bracken, R.P. Iyer, D.L. Berry, and T.J. Slaga: Anticarcinogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on benzo[a]pyrene and 7,12- dimethylbenz[a]anthracene tumor initiation and its relationship to DNA binding; Cancer Res. 39 (1979) 4027-4033.
34. DiGiovanni, J., D.L. Berry, G.L. Gleason, G.S. Kishore, and T.J. Slaga: Time-dependent inhibition by 2,3,7,8- tetrachlorodibenzo-p-dioxin of skin tumorigenesis with polycyclic hydrocarbons; Cancer Res. 40 (1980) 1580-1587.
35. Van Duuren, B.L., A. Sivak, C. Katz, and S. Mel-chionne: Cigarette smoke carcinogenesis: Importance of tumor promoters; J. Natl. Cancer Inst. 47 (1971) 235-240.
36. Lesca, P.: Protective effects of ellagic acid and other plant phenols on benzo[a]pyrene-induced neoplasia in mice; Carcinogenesis 4 (1983) 1651-1653.
37. Wattenberg, L.W. and W.D. Loub: Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles; Cancer Res. 38 (1978) 1410-1412.
38. Sunderman, F.W., K.S. McCully, S.B. Taubman, P.R. Allpass, M.C. Reid, and L.A. Rinehimer: Manganese inhibition of sarcoma induction by benzo[a]pyrene in rats; Carcinogenesis 1 (1980) 613-620.
39. Lam, L.K.T., R.P. Pai, and L.W. Wattenberg: Synthesis and chemical carcinogen inhibitory action of 2-tert-butyl-4-hydroxyanisole; J. Med. Chem. 22 (1979) 569-571.
40. Slaga, T.J. and W.M. Bracken: The effect of antioxidants on skin tumor initiation and aryl hydrocarbon hydroxylase; Cancer Res. 37 (1977) 1631-1635.
41. Slaga, T.J., V.I. Solanki, and M. Logani: Studies on the mechanism of action of antitumor promoting agents: Suggestive evidence for the involvement of free radicals in promotion; in: Radioprotectors and anticarcinogens, edited by O.F. Ngaard and M.G. Simic, Academic Press, New York, NY (1983) 471-485.
42. Wattenberg, L.W.: Inhibition of carcinogenic and toxic effects of polycyclic hydrocarbons by phenolic antioxidants and ethoxyquin; J. Natl. Cancer Inst. 48 (1972) 1425-1430.
43. International Agency for Research on Cancer (IARC): Chrysene; in: Evaluation of the carcinogenic risk of chemicals to humans: Polynuclear aromatic hydrocarbons. Part 1. Chemical, environmental and experimental data; IARC, Lyon, France, IARC Monograph 32 (1983) 247-261.
44. DiGiovanni, J., T.J. Slaga, D.L. Berry, and M.R. Juchau: Inhibitory effects of environmental chemicals on polycyclic aromatic hydrocarbon carcinogenesis; in: Carcinogenesis. A comprehensive survey. Vol. 5, edited by T.J. Slaga, Raven Press, New York, NY (1980) 145-168.
45. Slaga, T.J., L. Jecker, W.M. Bracken, and C.E. Weeks: The effects of weak or non-carcinogenic polycyclic hydrocarbons on 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene; Cancer Lett. 7 (1979) 51-59.
46. Homburger, F., A. Treger, and E. Boger: Inhibition of murine subcutaneous and intravenous benzopentaphene carcinogenesis by sweet orange oils and d-limonene; Oncology 25 (1971) 1-10.
47. Mathews-Roth, M.M.: Antitumor activity of β-carotene, canthaxanthin, and phytoene; Oncology 39 (1982) 33-37.
48. Slaga, T.J. and R.K. Boutwell: Inhibition of the tumorinitiating ability of the potent carcinogen 7,12-dimethylbenz[a]anthracene by the weak tumor initiator 1,2,3,4- dibenzanthracene; Cancer Res. 37 (1977) 129-133.
49. Slaga, T.J., A. Viaje, S.G. Buty, and W.M. Bracken: Dibenz[a,c]anthracene: A potent inhibitor of skin-tumor initiation by 7,12-dimethylbenz[a]anthracene; Res. Comm. Chem. Pathol. Pharmacol. 19 (1978) 477-483.
50. Saito, Y., H. Takizawa, S. Konishi, D. Yoshida, and S. Mizusaki: Identification of cembratriene-4,6-diol as an antitumor-promoting agent from cigarette smoke condensate; Carcinogenesis 6 (1985) 1189-1194.
51. Shamberger, R.J.: Inhibitory effect of vitamin A on carcinogenesis; J. Natl. Cancer Inst. 47 (1971) 667-673.
52. Perchellet, J.-P. and R.K. Boutwell: Effects of 3-iso-butyl-1-methylxanthine and cyclic nucleotides on the biochemical processes linked to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate; Cancer Res. 41 (1981) 3927-3935.
53. Wattenberg, L.W.: Inhibition of carcinogenic effects of polycyclic hydrocarbons by benzyl isothiocyanate and related compounds; J. Natl. Cancer Inst. 58 (1977) 395-398.
54. Wattenberg, L.W.: Inhibition of carcinogen-induced neoplasia by sodium cyanate, tert-butyl isocyanate, and benzyl isothiocyanate subsequent to carcinogen exposure; Cancer Res. 41 (1981) 2991-2994.
55. Klein, M.: Inhibition of skin tumorigenesis in Strain B6AF1/J female mice with maleic anhydride; J. Natl. Cancer Inst. 34 (1965) 175-183.
56. Shamberger, R.J.: Relationship of selenium to cancer. I. Inhibitory effect of selenium on carcinogenesis; J. Natl. Cancer Inst. 44 (1970) 931-936.
57. Yasukawa, K., M. Takido, T. Matsumoto, M. Takeuchi, and S. Nakagawa: Sterol and triterpene derivatives from plants inhibit the effects of a tumor promoter and sitosterol and betulic acid inhibit tumor formation in mouse skin two-stage carcinogenesis; Oncology 48 (1991) 72-76.
58. Shklar, G.: Oral mucosa carcinogenesis in hamsters. Inhibition by vitamin E; J. Natl. Cancer Inst. 68 (1982) 791-797.
59. Viaje, A., T.J. Siege, M. Wigler, and I.B. Weinstein: Effects of anti-inflammatory agents in mouse skin tumor promotion, epidermal DNA synthesis, phorbol esterinduced cellular proliferation, and production of plasminogen activator; Cancer Res. 37 (1977) 1530-1536.
60. Weerapradist, W. and G. Shklar: Vitamin E inhibition of hamster buccal pouch carcinogenesis; Oral Surg. 54 (1982) 304-312.
61. Van Duuren, B.L., J.A. Bilbao, and C.A. Joseph: The origin and nature of the nitrogen heterocyclics in cigarette smoke condensate; Proc. Am. Chem. Soc. Mtg.-In- Miniature, New York, NY (1960); The carcinogenic nitrogen heterocycles in cigarette smoke condensate; J. Natl. Cancer Inst. 25 (1960) 53-61.
62. Rodgman, A.: Tobacco smoke components. Letter to the Editor; Beitr. Tabakforsch. Int. 18 (1998) 127-129.
63. Baker, R.R.: Smoke chemistry; Chapter 12 in: Tobacco: Production, chemistry and technology, edited by D.L. Davis and M.T. Nielsen, Blackwell Science, Oxford, UK (1999) 398-439.
64. Rodgman, A.: A comparison of the chemical, physical, and biological properties of cigarette mainstream smoke (MS), cigarette sidestream smoke (SS), and environmental tobacco smoke (ETS); Report submitted to the U. S. Environmental Protection Agency (December 1991; revised July 1992), pp. i-vii + 1-117, see www.rjrtdocs.com 512527469-7599, 521184527-4657.
65. Candeli, A., D. Hoffmann, and E.L. Wynder: Unpublished 1963 data cited in E. L. Wynder and D. Hoffmann: Experimental tobacco carcinogenesis; Adv. Cancer Res. 8 (1964) 249-453, see 323-333; also cited in: E. L. Wynder and D. Hoffmann: Tobacco and tobacco smoke: Studies in experimental carcinogenesis; Academic Press, New York, NY (1967), see pp. 373-374, Table VIII-14.
66. Wynder, E.L. and D. Hoffmann: Experimental tobacco carcinogenesis; Adv. Cancer Res. 8 (1964) 249-453.
67. Kaburaki, Y., S. Sugawara, U. Kobashi, and T. Doihara: Studies on the composition of tobacco smoke. XIV. The formation of pyridines in the pyrolysis of nicotine; J. Agr. Chem. Soc. Japan 44 (1970) 224-231.
68. Schmeltz, I., W.S. Schlotzhauer, and E.B. Higman: Characteristic products from pyrolysis of nitrogenous organic substances; Beitr. Tabakforsch. 6 (1972) 134-138.
69. Schmeltz, I., A. Wenger, D. Hoffmann, and T.C. Tso: Use of radioactive tracers to determine cigarette smoke components that arise from nicotine during combustion; 31st Tobacco Chemists' Research Conference, Program Booklet and Abstracts, Vol. 31, Paper No. 17, 1977, p. 9; Chemical studies on tobacco smoke. 63. On the fate of nicotine during pyrolysis and in a burning cigarette; J. Agr. Food Chem. 27 (1979) 602-608.
70. Snook, M.E.: Gel elution of heterocyclic analogues of polynuclear aromatic hydrocarbons from bio-beads; Anal. Chim. Acta 99 (1978) 299-304.
71. Snook, M.E., P.J. Fortson, L.B. Smith, and O.T. Chortyk: Isolation and identification of aza-arenes of tobacco smoke; 32nd Tobacco Chemists' Research Conference, Program Booklet and Abstracts, Vol. 32, Paper No. 46, 1978, p. 25; Snook, M.E., P.J. Fortson, and O.T. Chortyk: Isolation and identification of aza-arenes of tobacco smoke; Beitr. Tabakforsch. Int. 11 (1981) 67-78. 70a.Grimmer, G., K.W. Naujack, and G. Dettbarn: Gas chromatographic determination of polycyclic aromatic hydrocarbons, aza-arenes, aromatic amines in the particle and vapor phase of mainstream and sidestream smoke of cigarettes; Int. Exptl. Symp. on Passive Smoking, Essen, Germany; Gas chromatographic determination of polycyclic aromatic hydrocarbons, aza-arenes, aromatic amines in the particle and vapor phase of mainstream and sidestream smoke of cigaretttes; Toxicol. Lett. 35 (1987) 117-124.
72. Kamata, K., N. Motohashi, R. Meyer, and Y. Yama-moto: Analysis of benz[c]acridines in cigarette smoke by high-performance liquid chromatography; J. Liq. Chromatog. 15 (1992) 1907-1920.
73. Sasaki, T.A. and S.C. Moldoveanu: Analysis of dibenz [a,j]acridine in particulate-phase cigarette smoke; 53rd Tobacco Science Research Conference, Program Booklet and Abstracts, Vol. 53, Paper No. 32, 1999. p. 37; Determination of dibenz[a,j]acridine in the particulate phase of cigarette smoke; Beitr. Tabakforsch. Int. 19 (2000) 25-31.
74. Rustemeier, K., R. Stabbert, H.J. Haussmann, E. Roemer, and E.L. Carrnines: Evaluation of the potential effects of ingredients added to cigarettes. Part 2: Chemical composition of mainstream smoke; Food Chem. Toxicol. 40 (2002) 93-104.
75. Schüller, H.M., A. Castonguay, M. Orloff, and G. Rossignol: Modulation of the uptake and metabolism of 4-(N-methylnitrosamino)-1-(3-pyridyl)-1-butanone by nicotine; Cancer Res. 51 (1991) 2009-2114.
76. Lee, C.K., C.W. Fulp, D.W. Bombick, and D.J. Doolittle: Inhibition of mutagenicity of N-nitrosamines by tobacco smoke and its constituents; Mutation Res. 367 (1996) 83-92.
77. Lee, C.K., J.A. Munoz, C.W. Fulp, K.-M. Chang, J.C. Rogers, M.F. Borgerding, and D.J. Doolittle: Inhibitory activity of cigarette-smoke condensate on the mutagenicity of heterocyclic amines; Mutation Res. 322 (1994) 21-32.
78. Cohen, B.I., R.F. Raicht, and E. Fazzini: Reduction of Nmethyl-N-nitrosourea-induced colon tumors in the rat by cholesterol; Cancer Res. 42 (1982) 5050-5052.
79. Takeda, K., S. Ukawa, and M. Mochizuki: Inhibition by fatty acids of direct mutagenicity of N-nitroso compounds; in: Relevance to human cancer of N-nitroso compounds, tobacco and mycotoxins, edited by I.K. O'Neill, J. Chen, and H. Bartsch, IARC, Lyon, France, IARC Sci. Publ. No. 105 (1991) 558-563.
80. Mirvish, S.S., A. Cardesa, L. Wallcave, and P. Shubik: Induction of lung adenomas by amines or ureas plus nitrite and by N-nitroso compounds: Effects of ascorbate, gallic acid, thiocyanate, and caffeine; J. Natl. Cancer Inst. 55 (1975) 633-636.
81. Thompson, H.J.: Effect of deficiencies of selenium and vitamin E alone or in combination on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea; Carcinogenesis 12 (1991) 2175-2179.
82. Matsumoto, M., R. Oyashu, M.L. Hopp, and T. Kitajima: Suppression of dibutylnitrosamine-induced bladder cancer carcinomas in hamsters; J. Natl. Cancer Inst. 58 (1977) 1825-1829.
83. Wattenberg, L.W. and J.B. Coccia: Inhibition of 4- methylnitrosamino-1-(3-pyridyl)-1-butanone carcinogenesis in mice by d-limonene and citrus fruit oils; Carcinogenesis 12 (1991) 115-117.
84. Lo, L.W. and H.F. Stich: The use of short-term tests to measure the preventive action of reducing agents on formation and activation of carcinogenic nitroso compounds; Mutat. Res. 57 (1978) 57-67.
85. Teel, R. and A. Castonguay: Antimutagenic effects of polyphenolic compounds; Cancer Lett. 66 (1992) 107-113.
86. Schüller, H.M., A. Castonguay, M. Orloff, and G. Rossignol: Modulation of the uptake and metabolism of 4-(N-methylnitrosamino)-1-(3-pyridyl)-1-butanone by nicotine; Cancer Res. 51 (1991) 2009-2114.
87. Chung, F.L., M.A. Morse, K.I. Eklind, and Y. Xu: Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis by compounds derived from cruciferous vegetables and green tea; in: Tobacco smoking and nutrition: Influence of nutrition on tobacco-associated health risks, edited by J.N. Diana and W.A. Pryor, Ann. NY Acad. Sci. 686 (1993) 186-202.
88. Farinati, F., Z. Zhou, J. Bellah, C.S. Liebers, and A.J. Garro: Effect of chronic ethanol consumption on activation of nitrosopyrrolidine to a mutagen by rat upper alimentary tract, lung and hepatic tissue; Drug Metab. Dispos. 13 (1985) 210-214.
89. Waddell, W. and C. Marlowe: Inhibition by alcohols of the localization of radioactive nitrosonornicotine in sites of tumor formation; Science 221 (1983) 51-52.
90. Chung, F.L., A. Juchatz, J. Vitarius, and S.S. Hecht: Effects of dietary compounds on α-hydroxylation of N- nitrosopyrrolidine and N'-nitrosonornicotine in rat target tissues; Cancer Res. 44 (1984) 2924.
91. Chung, F.L., A. Juchatz, J. Vitarius, B. Reiss, and S.S. Hecht: Inhibition of target tissue activation of N'- nitrosonornicotine and N-nitrosopyrrolidine by dietary components; in: N-Nitroso compounds: Occurrence, biological effects and relevance to human cancer, edited by I.K. O'Neill, R.C. von Borstel, C.T. Miller, J. Long, and H. Bartsch, IARC, Lyon, France, IARC Sci. Publ. No. 57 (1984) 797-804.
92. Hoffmann, D., K.D. Brunnemann, J.D. Adams, and S.S. Hecht: Formation and analysis of N-nitrosamines in tobacco products and their endogenous formation in consumers; in: N-Nitroso compounds: Occurrence, biological effects and relationship to human cancer, edited by I.K. O'Neill, R.C. von Borstel, C.T. Miller, J. Long, and H. Bartsch, IARC, Lyon, France, IARC Sci. Publ. No. 57 (1984) 743-762.
93. Environmental Protection Agency: Maleic hydrazide: Notification of issuances of notice of intent to suspend pesticide registration; Fed. Reg. 46 (No. 179) (1981) 45999-46000.
94. Clapp, N.K., R.L. Tyndall, L.C. Satterfield, W.C. Klima, and N.D. Bowles: Selective sex-related modification of diethylnitrosamine-induced carcinogenesis in Balb/C mice by concomitant administration of butylated hydroxytoluene; J. Natl. Cancer Inst. 61 (1978) 177-182.
95. Clapp, N.K., N.D. Bowles, L.C. Satterfield, and W.C. Klima: Selected protective effect of butylated hydroxytoluene against 1,2-dimethylhydrazine carcinogenesis; J. Natl. Cancer Inst. 63 (1979) 1081-1087.
96. Wynder, E.L., D.A. Goodman, and D. Hoffmann: Ciliatoxic components in cigarette smoke. II. Carboxylic acids and aldehydes; Cancer 18 (1965) 505-509.
97. Wynder, E.L. and D. Hoffmann: Reduction of tumorigenicity of cigarette smoke. An experimental approach; J. Am. Med. Assoc. 192 (1965) 88-94.
98. Rodgman, A., S.S. Mims, and L.C. Cook: Some comments on ciliary inhibition; RDM, 1964, No. 45, April 28, 500602286-2294.
99. Dalhamn, T., M.L. Edfors, and R. Rylander: Mouth absorption of various compounds in cigarette smoke; Arch. Environ. Hlth. 16 (1968) 831-835; Retention of cigarette smoke components in human lungs; Arch. Environ. Hlth. 17 (1968) 746-748.
100. Boutwell, R.K., H.P. Rusch, and D.K. Bosch: The action of phenols and related compounds in tumor formation; Proc. Am. Assoc. Cancer Res. (1) (1955) 6-7; Boutwell, R.K., H.P. Rusch, and B. Booth: Tumor production by phenol and related compounds; Proc. Am. Assoc. Cancer Res. 2(2) (1956) 96; Boutwell, R.K. and D.K. Bosch: The tumor-promoting action of phenols and related compounds for mouse skin; Cancer Res. 19 (1959) 413-424.
101. Hoffmann, D. and E.L. Wynder: Die Filtration von Phenolen aus Cigarettenrauch [The filtration of phenols from cigarette smoke]; Beitr. Tabakforsch. 2 (1963) 51-66; Filtration of phenols from cigarette smoke; J. Natl. Cancer Inst. 30 (1963) 67-84.
102. Laurene, A.H.: Adsorption of phenol by untreated Estron® RDM, 1963, No. 5, January 8, see www.rjrtdocs.com 500612340-2343; Evaluation of triacetate B as a cigarette filter material; RDM, 1963, No. 6, January 8, see www.rjrtdocs.com 500612344-2346; A.H.: The effect of cigarette moisture content on component analysis of smoke; RDM, 1965, No. 17, February 22, see www.rjrtdocs.com 500602612-2614.
103. Laurene, A.H., G.W. Young, and L.A. Lyerly: Phenol content in smoke as a function of the age of the cigarette; RDM, 1963, No. 17, February 19, see www.rjrtdocs.com 500612411-2420; Factors which affect the phenol content of cigarette smoke; RDR, 1963, No. 58, November 13, see www.rjrtdocs.com 500962130-2163.
104. Spears, A.W.: Selective filtration of volatile phenolic compounds from cigarette smoke; Tob. Sci. 7 (1963) 76-80.
105. Rodgman, A. and T.A. Perfetti: The chemical components of tobacco and tobacco smoke; CRC Press, Taylor and Francis Group, Boca Raton, FL, 2008.
106. Hoffman, H.E. and A.C. Griffin: Action of cigarette tar and smoke on chemically induced carcinogenesis; Texas Rep. Biol. Med. 16 (1958) 333-345.
107. Falk, H.L., P. Kotin, and S. Thompson: Inhibition of carcinogenesis. The effect of hydrocarbons and related compounds; Arch. Environ. Health 9 (1964) 169-179.
108. Homburger, F. and A. Treger: Effects of intravenous carcinogen and tobacco condensate injections upon the incidence of lung tumors in A/He mice; in: Lung tumors in animals, edited by L. Severi, Division of Cancer Research, University of Perugia, Italy, 1965, pp. 527-536.
109. Wynder, E.L. and D. Hoffmann: Experimental tobacco carcinogenesis; Science 162 (1968) 862-871.
110. Hecht, S.S., R.L. Thorne, and D. Hoffmann: Studies on tumor promoters in tobacco smoke; 28th Tobacco Chemists' Research Conference, Program Booklet and Abstracts, Vol. 28, Paper No. 42, 1974, p. 28, for presentation text, 501527005-7015.
111. Roe, F.J.C.: The role of 3,4-benzopyrene in carcinogenesis by tobacco smoke condensate; Nature 194 (1962) 1089-1090; Role of 3,4-benzopyrene in carcinogenesis by tobacco smoke condensate; Acta Unio Internat. Contra Cancrum 19 (1963) 730.
112. Lazar, P.H., I. Chouroulinkov, C. Libermann, and M. Guerin: Amounts of 3,4-benzpyrene (3,4-BP) in cigarette smoke condensates and carcinogenicity; 9th Internat. Cancer Cong., Tokyo, Japan (1966); Benzo[a]- pyrene content and carcinogenicity of cigarette smoke condensate: Results of short-term and long-term tests; J. Natl. Cancer Inst. 37 (1966) 573-579.